| 期刊論文1. | Yi, T.、Wan, J. L.、Xu, H. B.、Yang, X. L.(2008)。A new solid self-microemulsifying formulation prepared by spray-drying to improve the oral bioavailability of poorly water soluble drugs。Eur. J. Pharm. Biopharm,70,439-444。 | 2. | Yi, T.、Wan, J. L.、Xu, H. B.、Yang, X. L.(2008)。Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose。Eur. J. Pharm. Sci,34,274-280。 | 3. | Ferrari, M.(2005)。Cancer nanotechnology: opportunities and challenges。Nature Reviews Cancer,5,161-171。 | 4. | Ambudkar, S. V.、Kimchi-Sarfaty, C.、Sauna, Z. E.、Gottesman, M. M.(2003)。Pglycoprotein: from genomics to mechanism。Oncogene,22,7468-7485。 | 5. | Senior, A. E.、al-Shawi, M. K.、Urbatsch, I. L.(1995)。The catalytic cycle of P-glycroprotein。FEBS Lett,377,285-289。 | 6. | Higgins, C. F.(1991)。Molecular basis of multidrug resistance mediated by Pglycoprotein。Curr. Opin. Biotechnol,2,278-281。 | 7. | en, C. J.、Chin, J. E.、Ueda, K.、Pastan, O.、Gottesman, M. M.、Roninson, I. B.(1986)。Internal duplication and homology with bacterial transport proteins in the mdrl (P-glycoprotein) gene from multi-drug resistance human cells。Cell,47,381-389。 | 8. | Loth, P. T.、Lou, H. X.、Zhao, Y.、Chin, Y. M.、Vathsala, A.(2008)。Significant impact of gene polymorphisms on tacrolimus but not cyclosporine dosing in Asian renal transplant recipients。Transplant. Proc,40,1690-1695。 | 9. | Akiyama, S. I.、Cornwell, M. M.、Kuwano, M.、Pastan, I.、Gottesman, M. M.(1988)。Most drugs that reverse multidrug resistance also inhibit photoaffinity labelling of P-glycoprotein by vinblastine analog。Mol. Pharmacol,33,144-147。 | 10. | Mouly, S.、Paine, M. F.(2003)。P-glycoprotein increases from proximal to distal regions of human small intestines。Pharm. Res,20,1595-1599。 | 11. | Gottesman, M. M.、Pastan, I.(1993)。Biochemistry of multidrug resistance mediated by the multidrug transporter。Annu. Rev. Biochem,62,385-427。 | 12. | Wang, Q.、Bhardwaj, R. K.、Herrera-Ruiz, D.、Hanna, N. N.、Gudmundsson, O. S.、Buranachokpaisan, T.、Hidalgo, I. J.、Knipp, G. T.(2004)。Expression of multiple drug resistance conferring proteins in normal Chinese and Caucasian small and large intestinal tissue samples。Mol. Pharm,1,447-454。 | 13. | Peng, K. C.、Cluzeaud, F.、Bens, M.、Van Huyen, J. P.、Wioland, M. A.、Lacave, R.、Vandewalle, A.(1999)。Tissue and cell distribution of the multidrug resistanceassociated protein (MRP) in mouse intestine and kidne。J. Histochem. Cytochem,47,757-768。 | 14. | Cole, S. P. C.、Bhardwaj, G.、Gerlach, J. H.、Mackie, J. E.、Grant, C. E.、Almquist, K. C.、Deeley, R. G.(1992)。Over expression of a transporter gene in a multidrug-resistant human lung cancer cell line。Science,258,1650-1654。 | 15. | Zimmermann, C.、Gutmann, H.、Hruz, P.、Gutzwiller, J. P.、Beglinger, C.、Drewe, J.(2005)。Mapping of multidrug resistance gene 1 and multidrug resistance-associated protein isoform 1 to 5 mRNA expression along the human intestinal tract。Drug Metab. Dispos,33,219-224。 | 16. | Doyle, L. A.、Yang, W.、Abruzzo, L. V.、Krogmann, T.、Gao, Y.、Rishi, A. K.、Ross, D. D.(1999)。A multidrug resistance transporter from human MCF7 breast cancer cells。Proc. Natl. Acad. Sci. U.S.A.,95,15665-15670。 | 17. | Scheffer, G. L.、Maliepart, M.、Pijnenborg, A. C.、van Gastelen, M. A.、de Jong, M. C.、Schroeijers, A. B.、Scheper, R. J.(2000)。Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone and topotecan-resistant cell lines。Cancer Res,60,2589-2593。 | 18. | Gutmann, H.、Hruz, P.、Zimmermann, C.、Beglinger, C.、Drewe, J.(2005)。Distribution of breast cancer resitance protein (BCRP/ABCG2) mRNA expression along the human GI tract。Biochem. Pharmacol,70,695-699。 | 19. | Eisenblatter, T.、Galla, H. J.(2005)。A new multidrug resistance protein at the blood-brain barrier。Biochem. Biophys. Res. Commun,293,1273-1278。 | 20. | Martin, G. P.、Mariott, C.、Kellaway, I. W.(1978)。Direct effect of bile salts and phospholipids on the physical properties of mucus。Gut,19,1103-1107。 | 21. | Tomita, M.、Hyashi, M.、Horie, T.、Ishizawa, T.、Awazu, S.(1988)。Enhancement of colonic drug absorption by the transcellular permeation route。Pharm. Res,5,786-789。 | 22. | Ferte, J.(2000)。Analysis of tangled relationship between P-glycprotein mediated multidrug resistance and the lipid phase of the cell membrane。Eur. J. Biochem,267,277-294。 | 23. | Tayrouz, Y.、Ding, R.、Burhenne, J.、Riedel, K.-D.、Weiss, J.、Hoppe-Tichy, T.、Mikus, G.(2003)。Pharmacokinetic and pharmaceutic interaction between digoxin and cremophor RH40。Pharmacol. Ther,73,397-405。 | 24. | Wandel, C.、Kim, R. B.、Stein, C. M.(2003)。“Inactive” excipients such as Cremophor can affect in vivo drug disposition。Clin. Pharmacol. Ther,73,394-396。 | 25. | Rege, B. D.、Kao, J. P. Y.、Polli, J. E.(2002)。Effects of non-ionic surfactants on membrane transporters in Caco-2 cell monolayers。Eur. J. Pharm. Sci,16,237-246。 | 26. | Yamagata, T.、Kusuhara, H.、Morishita, M.、Takayama, K.、Benameur, H.、Sugiyama, Y.(2007)。Effect of excipients on breast cancer resistance protein substrate uptake activity。J. Control. Release,124,1-5。 | 27. | Yamagata, T.、Kusuhara, H.、Morishita, M.、Takayama, K.、Benameur, H.、Sugiyama, Y.(2007)。Improvement of the oral drug absorption of topotecan through the inhibition of intestinal xenobiotic efflux transporter, breast cancer resistance protein, by excipients。Drug Metab. Dispos,35,1142-1148。 | 28. | Hugger, E. D.、Novak, B. L.、Burton, P. S.、Audus, K. L.、Borchardt, R. T.(2002)。A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro。J. Pharm. Sci,91,277-294。 | 29. | Shen, Q.、Lin, Y.、Handa, T.、Doi, M.、Sugie, M.、Wakayama, K.、Yamamoto, A.(2006)。Modulation of intestinal P-glycoprotein function by polyethylene glycols and their derivatives by in vitro transport and in situ absorption studies。Int. J. Pharm,313,49-56。 | 30. | Hugger, E. D.、Audus, K. L.、Borchardt, R. T.(2002)。Effects of poly (ethylene glycol) on efflux transporter activity in Caco-2 cell monolayers。J. Pharm. Sci,91,1980-1990。 | 31. | Krylova, O. O.、Pohl, P.(2004)。Ionophoric activity of Pluronic block copolymers。Biochem,43,3696-3703。 | 32. | Baggetto, L. G.、Testa-Parussini, R.(1990)。Role of acetoin on the regulation of intermediate metabolism of Ehrlich ascites tumor mitochondria: its contribution to membrane cholesterol enrichment modifying passive proton permeability。Arch. Biochem. Biophys,283,241-248。 | 33. | Cerf, E.、Gasper, R.、Rychnovsky, S.、Chang, X. B.、Buyse. F.、Ruysschaert, J. -M.(2007)。Multidrug resistance protein 1 is not associated to detergent-resistant membranes. Biochem。Biochem. Biophys. Res. Commun,355,1025-1030。 | 34. | Shun, Y.、Liu, H.(2007)。Reversal of P-glycoprotein-mediated multidrug resistance by cholesterol derived from low density lipoprotein in vinblastine-resistant human lymphoblastic leukaemia cell line。Biochem. Cell Biol,85,638-646。 | 35. | Cui, S. X.、Nie, S. F.、Li, L.、Wang, C. G.、Pan, W. S.、Sun, J. P.(2009)。Preparation and evaluation of self-microemulsifying drug delivery system containing Vinpocetine。Drug. Dev. Ind. Pharm,35,603-611。 | 36. | Oh, D. H.、Kang, J. H.、Kim, D. W.、Lee, B. J.、Kim, J. O.、Yong, C. S.、Choi, H. G.(2011)。Comparison of solid self-microemulsifying drug delivery system (solid SMEDDS) prepared with hydrophilic and hydrophobic solid carrier。Int. J. Pharm,420,412-418。 | 37. | Huang, D.、Yi, T.、Liu, Y.、Xiao, L.、He, J. K.(2011)。Influence of hydroxypropylmethylcellulose on Digestion of Self-Microemulsifying Drug Delivery System in Gastro-Intestinal Tract in Vitro。Chin. Pharma. J.,7,527-531。 | 圖書1. | 楊祥良、曾繁典、徐輝碧(2007)。納米藥物。北京:清華大學出版社。 延伸查詢 | 2. | Balimane, P. V.、Chong, S.(2008)。Biopharmaceutics applications in drug development。Evaluation of Permeability and P-glycoprotein Interactions: Industry Outlook。 | |